Abstract
Atopic dermatitis (AD) is an allergic skin disease mediated by skin barrier dysfunction and an IL-13-driven immune response. The aryl hydrocarbon receptor (AHR) is a sensor molecule that is activated by numerus environmental ligands, some of which have shown promise in clinical trials of AD. Therefore, we hypothesized that the AHR pathway can attenuate IL-13-induced responses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
